Article Archive

Gilead tops Q1 revenue estimates but stock falls as acquisition costs and revised loss guidance cloud the outlook.

Guardant Health crushes Q1 estimates and hikes full-year guidance as cancer screening revenue soars on FDA wins.

Gen Digital surpasses $5B annual revenue milestone with accelerating double-digit growth, buoyed by rising cybersecurity demand.

Expedia Q1 EPS beat miss analyst expectations, yet stock fell as forward guidance disappointed travel investors.

EPAM drops 2.55% despite earnings beat and raised profit guidance, as analyst concerns over Q2 revenue outlook weigh on sentiment.

ENOV jumps nearly 10% on Q1 earnings beat and reaffirmed guidance, bouncing back from prior weakness.

ED slides 0.45% after mixed Q1 results, but reaffirms full-year adjusted EPS guidance at $6.00–$6.20.

DNA rises 2.4% after Q1 results and strategic divestiture, but company remains unprofitable with negative operating margins.

DIOD slides 3% despite launching high-speed redriver and clock generator chips for next-gen platforms.

Datadog's stock rockets 31% after Q1 earnings beat, marking a record trading day as observability platforms gain enterprise momentum.

CytomX's Q1 revenue more than doubled consensus, though per-share loss exceeded guidance in preliminary results.

BlackSky stock crashes 20% after missing Q1 targets but lifts full-year guidance on record contract wins.

BridgeBio's Q1 revenue surge powered by Attruby sales beat estimates, though EPS missed—stock authorizes $500M buyback.

AMPH reported Q1 adjusted EPS of $0.42 vs. $0.72 expected. Net revenues came in at $171.2M as the stock fell ~10% after hours.

A $1.8B cloud infrastructure commitment from a leading AI model provider overshadowed a Q1 EPS miss, sending AKAM shares up over 24% after hours.

Axcelis posted Q1 adj. EPS of $0.72, narrowly beating estimates, while Q2 guidance came in above consensus. Shares fell sharply on the day.

Airbnb posted Q1 revenue of $2.68B, up 17.9% YoY, beating estimates. EPS of $0.26 missed by 14.1%, yet the company raised its annual sales outlook.

Applied Optoelectronics shares fell sharply following its Q1 2026 earnings release. Revenue growth remains strong at 33.9% YoY, but margins stay negative.

A roundup of today's most significant stock moves and news across the market.

Fixed-income trading platform falls 1.6% despite record quarterly revenue and EPS beat as profit-taking offsets strong results.

Fast-food giant rises modestly after earnings beat on comparable sales strength fueled by value menu and Big Arch burger.

Consumer health stock rises 1.8% on earnings beat driven by margin growth, with pending Kimberly-Clark deal providing new catalyst.

Biotech stock slides 1.7% as Q1 revenue disappointed, though operating losses contracted as R&D spending moderated.

Aircraft parts maker surges 5.7% after Q1 beat and raised full-year guidance, signaling strong commercial and defense momentum.

Grainger jumped 3.09% after raising its 2026 profit outlook on robust demand for maintenance and services offerings across its industrial distribution network.

Green Plains dropped sharply after Q1 results revealed negative net margins and a 26.6% revenue decline year-over-year.

Gilead gained 2.11% as California's highest court signaled support for drugmakers' innovation rights in a closely-watched patent case.

Expedia Group appointed Derek Andersen, a Snap veteran, as its new CFO, signaling a leadership transition as the travel platform navigates competitive pressures.

Evergy topped first-quarter profit forecasts and reaffirmed full-year guidance, powered by regulated investment recovery and stronger customer demand.

EPAM topped Q1 2026 EPS estimates and lifted its full-year profit outlook, though a revenue miss kept the stock under pressure.

Enovis posted $589M in Q1 sales and $0.89 adjusted EPS, topping estimates. Reconstructive segment led growth as the company reiterated its full-year outlook.

Datadog posted $1.006B in Q1 revenue, up 32% YoY, beating estimates and issuing stronger-than-expected Q2 guidance. Shares rose nearly 24%.

CRL posted Q1 EPS of $2.06 and revenue of $995.8M, topping Wall Street estimates. Full-year guidance was reaffirmed amid ongoing portfolio reshaping.

BlackSky missed Q1 revenue estimates but secured $160M in new contracts and raised full-year guidance, sending shares sharply higher.

Disney jumped 7.54% as new CEO Josh D'Amaro's strategic initiatives drive streaming profitability, marking a major inflection point for the entertainment conglomerate.

CVS Health surged 7.65% on Q1 earnings beat and full-year guidance raise, as the healthcare conglomerate demonstrates margin expansion and operational momentum.

Carter's surged 11.67% after Q1 2026 earnings as the children's apparel retailer signaled improved operational efficiency with gross margins holding near 45%.

Cencora missed Q2 estimates but raised annual guidance, yet stock fell 17.38% as investors fret over near-term margin pressure in healthcare distribution.

Coherent topped Wall Street estimates on surging AI datacenter demand, with stock climbing 2.66% as the optics leader capitalizes on co-packaged optics momentum.

First-quarter net income of $615M smashes estimates as nitrogen pricing surges on Strait of Hormuz supply concerns.

Strong AI and IT infrastructure demand lifted Q1 revenue, but 20% stock drop suggests market disappointment elsewhere.

Silver miner's shares jump 9.46% as Q1 results benefit from elevated precious metals prices and operational gains.

Cloud software and connected devices propel 34% YoY Q1 revenue growth; company raises full-year forecast.

Utility raises full-year outlook as Q2 results demonstrate operational stability amid rate recovery efforts.

Arcutis Biotherapeutics posted strong ZORYVE revenue growth of 65% YoY in Q1 2026, though EPS of $(0.09) fell short of the $(0.06) consensus.

Arm Holdings surged 13.6% after posting record quarterly revenue and issuing above-consensus Q1 FY2027 guidance of $1.26B at midpoint.

APA reported Q1 2026 revenue of $2.33B, up 8.8% YoY, with non-GAAP EPS of $1.38 beating consensus by 20.9%. Shares fell 7.67% on the day.

Albemarle returned to profitability in Q1 2026, posting $319.1M in net income as rising lithium prices drove a more than sixfold jump in quarterly profit.

ADMA Biologics reported flat Q1 2026 revenue of $114.5M but delivered net income of $45.3M, while the FDA approved a pediatric label expansion for ASCENIV.

A roundup of today's most significant stock moves and news across the market.

MUR shares fell 1.14% after Q1 results revealed a 76.2% EPS collapse and negative operating margins, signaling energy sector distress.

MAR delivered Q1 revenue matching expectations and posted strong operating margins, though EPS growth of only 1.6% suggests limited near-term acceleration.

KHC topped Q1 revenue expectations and declared a $0.40 quarterly dividend, but negative net margins and declining earnings growth signal underlying weakness.

JCI beat Q2 revenue, raised full-year earnings guidance, and cited explosive data center cooling demand as a major growth driver.

GPN beat Q1 profit estimates and raised full-year guidance, though shares fell 3.25% in a broader market move.

Biotech Geron shares rose 5% following first-quarter results and plans to present at investor conferences, signaling catalysts ahead.

Utility Exelon exceeded first-quarter estimates driven by higher regulated rates and increased power demand across its footprint.

Gene-editing biotech Editas beat EPS expectations but missed revenue targets, reflecting slower-than-expected commercial progress.

Disney's streaming business turned a corner with robust profit growth, while parks and experiences posted strong results in Q2 2026.

CVS Health delivered Q1 EPS above estimates and lifted 2026 guidance, driving shares higher despite broader market pressure.

Carter's Q1 2026 net sales rose 8.1% to $681M, with U.S. Retail comparable sales up 10.5%. Shares trade at $33.34, up 0.51% on the day.

Cencora posted Q2 FY2026 revenue of $78.4B, missing estimates, but raised its annual profit outlook on steady specialty medicine demand.

COHR shares rose to $335.73 as investors position ahead of results. Analyst consensus remains firmly bullish with 22 Buy-or-better ratings.

CDW posted Q1 2026 revenue of $5.68B, up 9.2% YoY, beating Wall Street estimates on resilient IT spending. The stock trades at $136.80, up 1.11% on the day.

APA shares pull back slightly to $41.48 but remain close to their 52-week high of $45.66, supported by rising oil prices and a constructive cash flow outlook.

Palantir extended its Pentagon lock-in with a new multi-year AIP deployment contract — backed by US government revenue already up 45% to $320M last quarter, here's what it means for PLTR's valuation.

DVA gained 1.92% on Q1 beat and raised full-year guidance; dialysis demand remains resilient.

DUK ticked up 0.10% on Q1 beat; revenue grew 8% but earnings fell 2.2%, reflecting rate regulatory dynamics.

DD jumped 8.43% after beating Q1 expectations on cost initiatives; operating margin expanded significantly.

CTVA gained 2.71% on Q1 earnings beat; seed and crop protection demand remains robust ahead of 4Q separation.

CMI stock surged 2.76% on Q1 EPS beat and raised full-year guidance, driven by explosive AI infrastructure demand.

Chord Energy posted strong Q1 2026 results and updated guidance, though stock remains flat as energy sector navigates crude price headwinds.

Ball topped Q1 estimates but shares fell as year-over-year margin pressure and slowing operating leverage overshadowed the earnings beat.

Aptiv stock tumbled despite topping Q1 revenue and EPS estimates, as -43.4% EPS decline and modest 5% revenue growth signal underlying weakness.

Arista reported strong Q1 earnings and revenue, but shares tumbled as forward guidance disappointed despite robust AI equipment demand.

AMD stock jumped 4% after reporting Q1 EPS and revenue that topped expectations, fueled by strong AI infrastructure demand.

Assurant posted record Q1 2026 results with revenue up 11.3% YoY to $3.42B and non-GAAP EPS of $5.95, beating consensus by 11.7%. The company raised its full-year guidance.

American Electric Power posted Q1 2026 operating EPS of $1.64 and held its full-year guidance steady. Revenue rose 10% YoY as new load deals support long-term contracted growth.

Ameren posted Q1 2026 EPS of $1.28, topping the $1.18 consensus, as net income rose 23.5% year-over-year. Full-year EPS guidance of $5.25–$5.45 was reaffirmed.

ADPT reported a Q1 2026 net loss of $20M, or $0.13 per share, as shares fell 4.97%. Revenue growth of 51% YoY underscores the company's commercial momentum.

Archer-Daniels-Midland Q1 adjusted EPS of $0.71 topped estimates, driven by ethanol margins. Raised 2026 guidance sent shares to a new 52-week high.

A roundup of today's most significant stock moves and news across the market.

OXY gains 2.7% as markets await Q1 results, trading on elevated oil prices and strong gross margins that support shareholder returns.

MSTR climbs 3.7% as investors await Q1 earnings, tracking the company's aggressive bitcoin acquisition strategy and treasury expansion.

MPC surges 2.6% after Q1 beat driven by robust refining margins and 251% EPS growth, offsetting slight revenue decline.

LDOS tightens near flat on strong Q1 results and raised 2026 forecast, driven by robust defense and intelligence demand.

KBR stock rises 3.3% on Q1 revenue beat and 52% earnings-per-share growth, signaling momentum in engineering and defense.

Research and advisory firm Gartner beat Q1 expectations and lifted annual profit guidance, driven by elevated AI consulting demand.

Pet diagnostics leader IDEXX beat Q1 expectations and lifted full-year forecasts, signaling robust demand in veterinary care.

Dental distributor Henry Schein exceeded Q1 revenue expectations but reaffirmed annual guidance, suggesting base-case execution.

Defense contractor HII topped Q1 estimates but faced cost pressures that squeezed margins, a signal of execution risk ahead.

Eaton lifts full-year guidance to 10% organic growth after Q1 beat, though Q2 profit forecast signals near-term caution.

Duke Energy beat Q1 profit and revenue estimates, citing rate recovery and favorable weather, though earnings declined 2.2% year-over-year.

DuPont rose on strong Q1 earnings and lifted full-year profit and sales guidance, crediting pricing actions and operational discipline despite oil price volatility.

Corteva rose 1.04% as the company advances its planned separation, spinning off seed and genetics operations into standalone entity Vylor.

Aluminum packaging maker Ball delivered strong Q1 results, beating sales and profit estimates as beverage and food demand remained resilient.

Aptiv posted higher Q1 2026 profit and revenue on sustained auto parts demand. The EDS business spin-off into Versigent closed April 1, reshaping the company's structure.

AMD shares fell $19.00 to $341.54 amid broad market moves, even as the chipmaker's AI cloud traction and 34% revenue growth keep analyst sentiment firmly bullish.

American Electric Power topped Q1 2026 profit estimates and lifted its five-year capital plan to $78B, driven by rising data center power demand.

Archer-Daniels-Midland beat adjusted profit estimates in Q1 2026 despite missing revenue expectations. Grain trading margins provided the key lift.

Stock plummets 7% after Q2 revenue beat offset by widening operating losses and negative per-share earnings.

AI data center builder surges 21.6% on blowout Q1 earnings and raised full-year revenue and profit guidance.

Utility stock edges lower despite beating earnings estimates and posting 3% revenue growth in first quarter.

Stock jumps 1.4% as CEO Alex Karp delivers earnings beat on 70% revenue growth and surging government sales.

Chipmaker posts EPS beat and upbeat Q2 guidance on resilient automotive demand, though Q1 revenue fell short.

Cruise operator slides as profit outlook reduction and rising fuel costs amid geopolitical tensions weigh on the sector.

FPGA leader rallies after topping Q1 estimates and announcing major software acquisition to expand secure platform portfolio.

Insurance and diversified conglomerate falls as year-over-year profit drops in a sector weighing on equities.

Building products maker slides after Q1 2026 results reveal deepening profitability challenges and weak forward outlook.

Ichor shares jump 8.23% after posting mixed Q1 results but raising full-year outlook on robust demand recovery.

Fabrinet posted record Q3 FY2026 revenue and EPS of $3.72, beating guidance — yet shares fell 9.6% after hours on a narrow revenue miss.

FANG topped Q1 consensus on both revenue and EPS, raised its dividend, and boosted production guidance. Shares climbed 2.91% to $213.69.

BWX Technologies delivered a strong Q1 2026, with revenue of $860.2M and non-GAAP EPS beating consensus by 21%. The stock edged lower as the market had already priced in the momentum.

AXSM surged 8.31% to $223.70, clearing its prior 52-week high, after Q1 2026 revenue of $191.2M topped estimates. Launch costs remain a near-term drag on profitability.

Advanced Energy beat Q1 revenue estimates with 26% YoY growth, but weak Q2 EPS guidance sent shares down sharply in after-hours trading.

A roundup of today's most significant stock moves and news across the market.

Chevron shares slip 1.39% after EPS plunged 44.4% year-over-year, but negotiations for an Iraqi oilfield stake signal long-term growth potential.

Colgate stock rises despite flat EPS growth, as emerging market strength and 8.4% revenue growth balance elevated cost inflation.

ARE returns to profitability in Q1 2026 despite 11.5% revenue decline, as life sciences REIT stabilizes operations.

Oracle stock rallies on strong revenue growth of 21.7% and EPS expansion of 24.5%, driven by accelerating AI infrastructure and cloud adoption.

Clorox shares plunge 9.67% after Q1 margin expansion is overshadowed by cautious 2026 outlook and reduced forward guidance.

AMD gains modestly as AI chip demand remains robust, though geopolitical risk and elevated valuation merit caution.

AAPL gains 3.24% amid market recalibration on AI expenditure returns and Apple's disciplined capital allocation approach.

SPXC slides despite lifting revenue outlook, as higher leverage and tariff headwinds weigh on investor sentiment.

MTZ climbs 5.93% after posting record Q1 results and lifting full-year revenue outlook amid surging infrastructure demand.

AMZN gains as company opens logistics network to third-party sellers, driving diversified revenue growth.

MSFT rises to $414.44 on strong earnings growth and expanding AI partnerships across enterprise sectors.

INTC rallies as Berkshire subsidiary boosts stake to $78B, signaling confidence despite negative margins.

STRL rallies 3.31% as investors await Q1 results, but elevated valuation and negative earnings growth raise caution flags.

Palantir shares rose to $144.07 as strong fundamentals and broadening analyst conviction highlight the company's AI-driven commercial momentum.

Norwegian Cruise Line beat EPS estimates by 61% but missed revenue forecasts and cut its full-year outlook, sending shares lower before recovering.

Loews reported Q1 2026 net income of $337M, down from $370M a year ago, as revenue rose 1.4% YoY to $4.56B. Shares trade near 52-week highs.

FANG touched a 52-week high of $207.77 amid earnings anticipation and a broadly bullish analyst consensus. Wall Street remains firmly in the buy camp.

AXSM posted Q1 2026 revenue of $191.2M, up sharply year-over-year, but reported a net loss of $64.5M as commercial launch spending weighed on margins.

Shares tumble 9.67% as earnings growth stalls at 2.7% and revenue flatlines at 0.1% amid persistent consumer weakness.

Stock climbs on weekly momentum while carrying 352x trailing P/E ratio; profit margins of 3.95% lag legacy auto.

Stock dips 1.66% as company pursues $1.3B tariff refund claim while operating margin stagnates at 5.74%.

Stock drops sharply despite progress on R2 model as investors grapple with -63.6% profit margins and limited cash runway.

Shares jump 3% as stable pricing supports results while oral obesity medication gains early traction with physicians.

INTC jumped 5.44% to $99.62 amid broader semiconductor strength, though a -5.9% profit margin signals the chipmaker remains in restructuring mode.

AAPL jumped 3.24% to $280.14, entering buy-zone territory as technology earnings drove the S&P 500 and Nasdaq to fresh records for a fifth consecutive week.

AMZN edged up 1.21% after announcing a voice-activated proxy voting partnership with Vanguard, showcasing Alexa's deepening role in financial services.

MSFT gained 1.63% after securing major Pentagon AI contracts alongside Nvidia and Google, riding the mega-cap earnings wave to record highs.

XOM fell 1.02% as energy stocks weakened late afternoon, though the oil giant showed earnings strength amid market-wide gains.

NWL surges as Q1 earnings top estimates and management raises full-year outlook, signaling operational turnaround.

MRNA stock falls 1.24% as Q1 results show massive revenue decline and negative margins across the board.

LYB shares dip as Q1 results reveal negative margins and declining revenue, signaling sector stress in plastics.

LIN stock gains 1.35% as Q1 EPS beats estimates and management raises dividend, affirming industrial gas strength.

EL stock climbs 3.38% on Q3 earnings as the beauty giant demonstrates improved operational discipline.

Dominion Energy posted Q1 2026 operating EPS of $0.95, topping Wall Street estimates, with CVOW progress and reaffirmed 2026 guidance supporting investor confidence.

Chevron reported Q1 2026 adjusted EPS of $1.41, topping consensus as production volumes rose. Shares slipped 1.39% to $190.63 amid broader energy sector weakness.

Cboe Global Markets shares surged $26.87 on May 1 following an 8-K earnings filing. Net margin of 23.3% and 60.5% EPS growth underscore the strength.

A roundup of today's most significant stock moves and news across the market.

Azure and AI momentum offset by investor concerns over $190B capex plan impact on near-term profit growth.

Meta shares drop despite 62.4% earnings growth and 33.1% revenue expansion, signaling caution on future capex demands.

Class C shares surge on 31.1% earnings growth and strong operating leverage amid $700B hyperscaler AI spending.

Alphabet stock rallies on 18% revenue growth and 31.1% earnings expansion driven by cloud and AI infrastructure investments.

Exxon's Q1 upstream operations hit record levels, offsetting derivative timing hits and Middle East disruptions.

NWL surged 3.55% after beating Q1 expectations and raising full-year guidance, signaling stabilization in consumer products demand.

MRNA edged up 0.48% after beating Q1 revenue expectations as international sales and renewed COVID vaccine demand offset domestic weakness.

LYB surged 1.79% after beating Q1 adjusted EPS estimates amid geopolitical-driven market shifts and expectations for Q2 margin recovery.

LIN dropped 0.71% despite beating Q1 adjusted EPS estimates as the market had already priced in the forecast-beating results.

EL stock surged 1.35% after beating Q3 EPS estimates and raising full-year guidance despite a revenue miss.

Dominion Energy reported Q1 2026 net income of $621M ($0.69/share), down from $0.77 a year ago. Shares rose 3.2% to $64.50.

Chevron beat Wall Street's EPS forecast by 48% in Q1 2026, but net income dropped to $2.2B amid derivative charges and lower year-over-year revenue.

Colgate-Palmolive topped Q1 2026 estimates with EPS of $0.97 and revenue of $5.32B, up 8.4% YoY. Shares rose 1.03% to $85.36.

Church & Dwight beat Q1 2026 revenue and EPS estimates, with net sales of $1.47B and non-GAAP EPS of $0.95 — 2.3% above consensus.

Cboe Global Markets posted Q1 net income of $384.1M, or $3.66 per share. Shares dipped 1.80% as the stock retreats from near record levels.

First Solar surged 5.92% after delivering Q1 EPS and revenue beats while maintaining full-year 2026 guidance amid rising solar demand.

DexCom delivered higher-than-expected Q1 EPS but disappointed on revenue and reaffirmed full-year guidance, triggering after-hours selling.

DTE Energy rose 3.17% despite Q1 EPS miss, buoyed by talks to secure 2 GW of new industrial load under long-term contracts.

Clorox shares rose 1.76% despite cutting annual profit guidance on weak cleaning-product demand and persistent input cost pressures that squeeze margins.

Cigna edged up slightly despite a 0.60% decline as Q1 earnings beat consensus on strong Evernorth performance, with management raising full-year profit guidance.

Caterpillar surged 9.88% after Q1 results boosted a broader market rally, though earnings contracted 11.4% year-over-year despite solid 18% revenue growth.

Carrier jumped 8.79% after Q1 earnings as data center orders soared 500%, offsetting a slight revenue decline and offsetting prior-year earnings contraction.

Cardinal Health shares dropped 4.9% after Q3 earnings beat on EPS, but revenue underperformed and forward guidance concerns weigh.

BIO rose to $280.12 following Q1 2026 results, with the in vitro diagnostics specialist posting solid profitability metrics.

BBIO rose 0.24% with three analysts raising or maintaining Buy ratings and price targets ranging from $100 to $106.

Arthur J. Gallagher posted strong Q1 2026 revenue growth of 27.9% YoY to $4.76B. Non-GAAP EPS of $4.47 came in 1% above analyst estimates.

AIG delivered a strong Q1 2026 beat with adjusted EPS of $2.11 vs. $1.92 expected, driven by sharply lower catastrophe losses and an 11% dividend hike.

Apple reported Q2 revenue of $111.2B and EPS of $2.01, beating estimates, as Tim Cook prepares to hand the reins to John Ternus in September.

A roundup of today's most significant stock moves and news across the market.

DTE slipped 1.04% after Q1 EPS miss, though heavy infrastructure spending and revenue growth offer longer-term upside.

CytomX slipped 1.70% ahead of May 7 earnings announcement; biotech faces revenue collapse and mounting losses.

COP rose 3.16% on Q1 beat but slashed full-year guidance citing geopolitical disruptions to Qatar LNG operations.

Cigna surged 2.60% after Q1 EPS beat and full-year guidance hike, driven by robust Evernorth healthcare services performance.

CAT delivered record Q1 sales fueled by AI infrastructure demand, though stock dipped 0.96% as market digests results.

Stock barely moves after beating EPS and revenue estimates, but year-over-year earnings fell sharply.

Stock gains on third-quarter earnings beat and raised full-year guidance, reversing earlier sales weakness.

Shares dip 1.15% despite EPS beat and revenue growth driven by key pipeline assets, with full-year outlook maintained.

Stock drops 5.38% after Q1 earnings fell short on the bottom line, though revenue exceeded expectations.

Shares gain as three major analysts maintain buy ratings and raise price targets, citing Attruby's commercial promise.

AOS reported Q1 revenue of $945.6M, missing estimates by ~4%, and trimmed its full-year guidance. Shares are trading near a 52-week low.

Amgen shares slipped 0.46% as the FDA proposed withdrawing Tavneos approval. Q1 results are due imminently, with analyst consensus tilting toward Buy.

AMETEK delivered record Q1 revenue and raised its full-year outlook, while announcing a deal to acquire First Aviation Services. Shares trade near $227.87.

Arthur J. Gallagher declared a $0.70/share quarterly dividend and sees growing Wall Street conviction, with Buy ratings rising month-over-month.

Tim Cook's planned September departure and Apple's AI roadmap dominate investor attention as AAPL trades near $270. Analyst consensus remains firmly constructive.

Everest Group stock edges down despite Q1 earnings beat as revenue miss signals execution challenges despite profit strength.

eBay surges 3.4% after Q1 earnings beat, despite headwinds from earnings decline offsetting better-than-expected revenue.

Cognizant stock slips after Q1 beat as management issues cautious forward guidance amid IT budget uncertainty.

Carpenter stock dips 5% despite Q3 earnings beat and margin expansion as aerospace demand drives record profitability.

Chipotle stock surges after Q1 revenue beat, driven by unexpected comparable-restaurant sales growth.

C.H. Robinson beat Q1 EPS estimates despite reporting revenue below expectations, signaling cost discipline amid sector weakness.

Biogen jumped 6% after delivering a strong Q1 with broad-based product sales growth, led by Alzheimer's disease franchises.

American Water reported a Q1 earnings miss, though the company reaffirmed full-year guidance and raised its dividend.

Amphenol surged 3.24% on strong Q1 results, delivering 49.1% revenue growth and exceptional earnings expansion.

Amazon reported strong Q1 results with robust cloud revenue, though stock reaction remained muted despite earnings beat.

Allstate beat Q1 2026 revenue estimates and delivered EPS of $10.65, well above analyst expectations. Net income reached $2.46B as the stock trades near its 52-week high.

ALGN delivered a 12.8% EPS surprise in Q1 2026, with revenue up 6.2% YoY to $1.04B. Shares climbed over 5% in after-hours trading.

Aflac topped revenue estimates in Q1 2026 but fell short on EPS. Analyst sentiment has shifted notably more cautious in recent months.

Automatic Data Processing topped Q3 estimates with $3.63B in revenue and 7% growth, prompting management to raise its FY26 guidance.

AbbVie lifted its 2026 EPS guidance to $14.28 after Q1 EPS of $2.65 and $15B in revenue topped estimates, driven by Skyrizi and Rinvoq strength.

A roundup of today's most significant stock moves and news across the market.

FTAI plunges 6% to $216 on portfolio rotation pressure, masking robust 32.7% revenue growth and 29.8% earnings growth.

ETSY jumped on Q1 beat and steady demand, but shares fell 2.92% intraday as the forward P/E of 10.9x signals the market has already priced in recovery.

ETR gains traction after Q1 beat and long-term guidance hike, though elevated P/E of 28.9x signals premium pricing in the utility sector.

EG climbs 1.03% with a forward P/E of just 5.7x, the lowest among major insurance and business services peers, as Q1 results loom.

UBS lifted its price target to $110, signaling confidence in the marketplace ahead of earnings despite macro uncertainty.

Cognizant slipped on Q1 revenue miss and Q2 guidance below estimates, signaling cautious IT spending—offset partially by strategic $600M Astreya AI acquisition.

Carpenter Technology delivered Q3 FY2026 results with 25.9% earnings growth, though valuation at 49.7x trailing P/E suggests premium pricing.

Chipotle stock dipped 2.29% despite Wall Street optimism on its growth recipe, with FY earnings up just 4% and revenue growth at 4.9%.

Biogen shares rose 1.50% after beating Q1 revenue estimates, but management slashed full-year adjusted EPS guidance to $14.25–$15.25, signaling caution ahead.

Amphenol reports record first-quarter results with management signaling continued sales momentum through Q2 on broad end-market strength.

Amazon shares edge lower but hold near all-time highs. Analyst consensus remains firmly bullish as hyperscaler cloud spending faces a key market test.

ALL shares climb to $216.40, near their 52-week peak, as analyst consensus stays bullish ahead of Q1 results. Fundamentals show 103% EPS growth YoY and a 5.7x trailing P/E.

AFL shares climbed to $116.29 as Q1 results approach. Analyst consensus leans toward Hold amid declining revenue and net income growth.

ADP posted Q3 revenue of $5.94B and EPS of $3.37, beating estimates. Shares rallied over 4% as the company lifted its full-year 2026 forecast.

AbbVie topped Q1 2026 EPS estimates and lifted its full-year profit outlook, driven by immunology and neuroscience portfolio growth.